SYY
49
9
TJX
62
-2
IBM
47
-3
CTAS
53
-3
HIG
66
2
BK
74
3
DAL
84
-3
AMT
37
3
PYPL
52
-2
SWK
50
-5
AIZ
82
2
BBY
52
6
DD
53
-6
A
37
-2
RL
69
-4
M
31
-3
R
70
-3
LMT
30
-2
AXP
67
-2
BSX
64
-3
SYY
49
9
TJX
62
-2
IBM
47
-3
CTAS
53
-3
HIG
66
2
BK
74
3
DAL
84
-3
AMT
37
3
PYPL
52
-2
SWK
50
-5
AIZ
82
2
BBY
52
6
DD
53
-6
A
37
-2
RL
69
-4
M
31
-3
R
70
-3
LMT
30
-2
AXP
67
-2
BSX
64
-3
Financhill
Back

Perspective Therapeutics Vs. Neurogene Industry Stock Comparison

Sell
30

CATX
Perspective Therapeutics

Last Price:
7.88
Seasonality Move:
40.67%
Sell
1

NGNE
Neurogene

Last Price:
34.67
Seasonality Move:
50.43%
Sell
30
Perspective Therapeutics (CATX) is a Sell

Is Perspective Therapeutics a Buy, Sell or Hold?

  • The current Perspective Therapeutics [CATX] share price is $7.88. The Score for CATX is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • CATX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
1
Neurogene (NGNE) is a Sell

Is Neurogene a Buy, Sell or Hold?

  • The current Neurogene [NGNE] share price is $34.52. The Score for NGNE is 1, which is 98% below its historic median score of 50, and infers higher risk than normal.
  • NGNE is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

CATX Stock Price Chart

What is Perspective Therapeutics's stock price today?

  • The Perspective Therapeutics share price today is $7.88
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CATX is experiencing selling pressure, which indicates risk of future bearish movement.

NGNE Stock Price Chart

What is Neurogene's stock price today?

  • The Neurogene share price today is $34.52
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NGNE is experiencing selling pressure, which indicates risk of future bearish movement.

CATX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.91 Sell
Relative Strength Index (14 RSI): 19.21 Sell
Chaikin Money Flow: -1814221 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (10.47 - 12.81) Sell
Bollinger Bands (100): (11.15 - 14.37) Sell

NGNE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.55 Sell
Relative Strength Index (14 RSI): 35.74 Sell
Chaikin Money Flow: -452975 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (41.4 - 61.5) Sell
Bollinger Bands (100): (34.32 - 50.52) Sell

CATX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 10.48 Sell
20-day SMA: 11.39 Sell
50-day SMA: 12.61 Sell
200-day SMA: 12.8 Sell
8-day EMA: 10.03 Sell
20-day EMA: 11.13 Sell
50-day EMA: 12.15 Sell
200-day EMA: 11.67 Sell

NGNE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 53.3 Sell
20-day SMA: 51.47 Sell
50-day SMA: 46.76 Sell
200-day SMA: 38.99 Sell
8-day EMA: 47.13 Sell
20-day EMA: 50.2 Sell
50-day EMA: 47.47 Sell
200-day EMA: 38.44 Sell

Perspective Therapeutics Earnings Growth & CATX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.15 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.79 per share, and a decrease next year of $0.33 per share.

Neurogene Earnings Growth & NGNE Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.90 per share.

Perspective Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Neurogene Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):